Rituximab (International)

In the US, Rituximab (rituximab systemic) is a member of the following drug classes: antirheumatics, CD20 monoclonal antibodies and is used to treat Bullous Pemphigoid, Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Evan's Syndrome, Focal Segmental Glomerulosclerosis, Follicular Lymphoma, Granulomatosis with Polyangiitis, Immune Thrombocytopenia, Mantle Cell Lymphoma, Microscopic Polyangiitis, Non-Hodgkin's Lymphoma, Pemphigus Vulgaris, Rheumatoid Arthritis and Thrombocytopenia.

US matches:

• Rituximab
• Rituximab and hyaluronidase human, recombinant
• Rituximab-abbs
• Rituximab-arrx
• Rituximab-pvvr

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XC02

CAS registry number (Chemical Abstracts Service)

0174722-31-7

Chemical Formula

C6416-H9874-N1688-O1987-S44

Molecular Weight

143860

Therapeutic Categories

Immunosuppressant

Antineoplastic agent

Microtubule inhibitor

Biological response modifier, BRM

Anti-CD20 monoclonal antibody

Chemical Name

Immunoglobulin G 1 (human-mouse monoclonal IDEC-C2B8 gama 1-chain anti-human antigen CD 20), disulfide wit human-mouse monoclonal IDEC-C2B8 kapa-chain, dimer (WHO)

Foreign Names

• Rituximabum (Latin)
• Rituximab (German)
• Rituximab (French)
• Rituximab (Spanish)

Generic Names

• Rituximab (OS: BAN, DCF, USAN)
• Rituximab (Genetical Recombination) (OS: JAN)
• IDEC 102 (IDEC) (IS)
• IDEC C2B8 (IDEC) (IS)

Brand Names

• Acellbia
  Biocad, Georgia
• Blitzima
  Celltrion, Estonia; Celltrion, Slovenia; Celltrion Healthcare, Sweden; Celltrion Healthcare Hungary, Poland
• Mab Thera
  Roche Registration, Slovenia
• MabThera
  F. Hoffmann-La Roche, Macedonia; F. Hoffmann-La Roche LTD, Serbia; Hoffmann-La Roche Ltd, Latvia; Productos Roche, Chile; Roche, Armenia; Roche, Argentina; Roche, Bosnia & Herzegowina; Roche, Belgium; Roche, Brazil; Roche, Colombia; Roche, Cyprus; Roche, Czech Republic; Roche, Denmark; Roche, Ecuador; Roche, Estonia; Roche, Egypt; Roche, Spain; Roche, Finland; Roche, France; Roche, Georgia; Roche, Greece; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Ireland; Roche, Italy; Roche, Lebanon; Roche, Lithuania; Roche, Moldova; Roche, Myanmar; Roche, Mexico; Roche, Norway; Roche, New Zealand; Roche, Oman; Roche, Peru; Roche, Philippines; Roche, Poland; Roche, Paraguay; Roche, Russian Federation; Roche, Sweden; Roche, Thailand; Roche, Tunisia; Roche, Turkey; Roche, Taiwan; Roche, Venezuela; Roche, Vietnam; Roche, South Africa; Roche D.O.O., Serbia; Roche Pharmaceutical, China; Roche Products, United Kingdom; Roche Registration, Romania; Roche Registration Limited, Iceland; Roche Uruguay, Uruguay
• Mabthera
  Roche, Germany; Roche, Pakistan; Roche Products, Australia; Roche Registration, Netherlands
• MabThera 100mg
  Haemato Pharm, Austria; Inopha, Austria; Orifarm, Austria; Roche, Hungary; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland
• MabThera 10mg/ml
  Roche, Israel
• MabThera 1400mg
  Haemato Pharm, Austria; Orifarm, Austria; Roche, Israel; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland
• Mabthera 1400mg/11.7ml
  Roche, Luxembourg
• Mabthera 1600mg/13.4ml
  Roche, Luxembourg
• MabThera 500mg
  Haemato Pharm, Austria; Inopha, Austria; Orifarm, Austria; Roche, Hungary; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland
• MabThera SC
  Roche, Brazil; Roche Products, Australia
• Novex
  Elea, Argentina
• Reditux
  Complex Therapeutics, Chile; Dr Reddy's Lab, Myanmar; Dr. Reddy's Laboratories, Vietnam
• Rilast
  Hetero, Georgia
• Ritemvia
  Celltrion, Estonia; Celltrion Healthcare, Latvia; Celltrion Healthcare, Netherlands; Orion Pharma, Denmark; Orion Pharma, Finland; Orion Pharma, Sweden
• Ritemvia 500mg
  Celltrion Healthcare, Austria
• Rituxan
  Genentech, United States; Hoffmann-La Roche, Canada; Zenyaku Kogyo, Japan
• Rituxan Hycela [+ Hyaluronidase]
  Genentech, United States
• Rituximab
  Baxter, New Zealand
• Rituzena
  Celltrion Healthcare, Latvia; Celltrion Healthcare, Netherlands; Celltrion Healthcare, Sweden
• Rixanthon
  Sandoz, Latvia
• Rixathon
  Sandoz, Estonia; Sandoz, United Kingdom; Sandoz, Netherlands; Sandoz, Norway; Sandoz, Sweden; Sandoz, Slovenia; Sandoz GmbH, Greece
• Rixathon 100mg
  Hexal, Germany
• Rixathon 100mg/10ml
  Sandoz, Switzerland
• Rixathon 500mg
  Hexal, Germany
• Rixathon 500mg/50ml
  Sandoz, Switzerland
• Riximyo
  Sandoz, Estonia; Sandoz, Latvia; Sandoz, Netherlands; Sandoz, Sweden; Sandoz, Slovenia; Sandoz GmbH, Greece
• Truxima
  Biogaran, France; Celltrion, Georgia; Celltrion Healthcare, Lithuania; Celltrion Healthcare, Romania; Celltrion Healthcare Hungary Kft., Greece; Egis, Georgia; Kern Pharma, Spain; Mundipharma, Belgium; Mundipharma, Germany; Mundipharma Pharmaceuticals, Netherlands; Napp Pharmaceuticals, United Kingdom; Orion Pharma, Sweden
• Truxima 100mg
  Mundipharma, Luxembourg
• Truxima 100mg/10ml
  iQone, Switzerland
• Truxima 500mg
  Mundipharma, Luxembourg
• Truxima 500mg/50ml
  iQone, Switzerland
• Tuxella
  Celltrion, Estonia
• Zytux
  AryoGen, Georgia

Glossary

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer